TricodeAR (Respa Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Tricode drug offered from Respa Pharmaceuticals, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Respa Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: Chlorpheniramine Maleate, Codeine Phosphate, Pseudoephedrine Hydrochloride
SUBSTANCE NAME: CHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2011-06-20
END MARKETING DATE: 0000-00-00


Tricode AR HUMAN OTC DRUG Details:

Item DescriptionTricode AR from Respa Pharmaceuticals, Inc.
LABELER NAME: Respa Pharmaceuticals, Inc.
DEA SCHEDULE: CV
ACTIVE STRENGTH: 2; 8; 30(mg/5mL; mg/5mL; mg/5mL)
START MARKETING DATE: 2011-06-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60575-313_cfbbbfc0-ceb1-42b7-927b-6dcc58e30f1f
PRODUCT NDC: 60575-313
APPLICATION NUMBER: part341

Other CHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Qualitest PharmaceuticalsPhenylhistine DH
Respa Pharmaceuticals, Inc.Tricode